Ron Cohen

2018

In 2018, Ron Cohen earned a total compensation of $2.4M as President and Chief Executive Officer at Acorda Therapeutics, a 20% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,610,446
Salary$795,675
Other$8,250
Total$2,414,371

Cohen received $1.6M in non-equity incentive plan, accounting for 67% of the total pay in 2018.

Cohen also received $795.7K in salary and $8.3K in other compensation.

Rankings

In 2018, Ron Cohen's compensation ranked 4,818th out of 14,244 executives tracked by ExecPay. In other words, Cohen earned more than 66.2% of executives.

ClassificationRankingPercentile
All
4,818
out of 14,244
66th
Division
Manufacturing
1,811
out of 5,765
69th
Major group
Chemicals And Allied Products
658
out of 2,128
69th
Industry group
Drugs
553
out of 1,817
70th
Industry
Biological Products, Except Diagnostic Substances
111
out of 339
67th

Pay ratio

Ron Cohen's Pay$2,414,371
Median Employee's Pay$202,725
Pay Ratio

12

to 1

In 2018, the annual total compensation of Ron Cohen was $2,414,371.

The annual total compensation of the median employee at Acorda Therapeutics was $202,725.

The ratio of Ron Cohen's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 26, 2019.

Cohen's colleagues

We found five more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2018.

2018

Jane Wasman

Acorda Therapeutics

General Counsel

2018

Burkhard Blank

Acorda Therapeutics

Chief Medical Officer

2018

Andrew Hindman

Acorda Therapeutics

Chief Business Officer

2018

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2018

David Lawrence

Acorda Therapeutics

Chief, Business Operations and Principal Accounting Officer

News

You may also like